

November 2024: Obstetrics Part #1
Oct 17, 2024
Dive into the latest advancements in managing diabetes during pregnancy, where expert insights highlight the role of continuous glucose monitoring in improving outcomes. Discover innovative diagnostic methods for hyperglycemia, focusing on the urgent need for early detection. A new multi-center trial aims to shed light on glucose metabolism's impact on pregnancy. The discussion underscores the significance of research in transforming prenatal care and enhancing the health of both mothers and babies.
AI Snips
Chapters
Transcript
Episode notes
Field Progress Yet Persistent Challenges
- The Diabetes and Pregnancy issue shows large progress in including pregnant people with diabetes in research.
- Despite advances, problems like diabetic ketoacidosis still cause preventable poor perinatal outcomes and need more work.
Early CGM Signals Predict Perinatal Risk
- Continuous glucose monitoring (CGM) detected early pregnancy glycemic patterns linked to later adverse perinatal outcomes like LGA and hypertensive disorders.
- Early higher mean glucose and increased time above 120–140 mg/dL associated with those outcomes, suggesting predictive value.
Motivation Rooted In Early CGM Adoption
- Dr. Celeste Durnwald began the work because CGM was new in 2020 and she wanted to capture early pregnancy glycemic signals.
- She aimed to use innovative monitoring to better understand pathophysiology behind outcomes like LGA and hypertensive disorders.